Tailored Afib Care Called For
Emerging technology might provide a more personalized approach to help reduce the death and morbidity in atrial fibrillation patients, according to a European consensus statement.
Management and treatment of Afib patients should encompass the integration of atrial morphology and damage, brain and heart imaging, information on genetic predisposition, systemic or local inflammation, and blood-based biomarkers, according to Paulas Kirchoff, MD, of the University of Birmingham Centre for Cardiovascular Sciences in Birmingham, England, and colleagues.
The authors proposed a new taxonomy of atrial fibrillation based on its pathophysiology and suggested that each patient be assigned to only one group, they wrote in the study published online in Europace.
The Afib classifications are monogenic, polygenic, focally induced, postoperative, complex types of Afib such as valvular atrial fibrillation, Afib in the elderly, and unclassified.